COMMUNIQUÉS West-GlobeNewswire

B. Braun Awarded Best Research Article of 2018 by BI&T
09/08/2019
First-of-its-kind Study Reveals Impact of Infusion Pump Alarms on Patients and Clinicians BETHLEHEM, Pa., Aug. 09, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. announced that it has been selected by the Association [...]
Two clinical trials with Acetium® capsule for prevention of migraine-type headache have been concluded
09/08/2019
Biohit Oyj Stock Exchange Release August 9th 2019 at 15.30 pm local time (EET) In 2014, Biohit Oyj initiated two clinical trials for prevention of migraine-type headache attacks, testing the efficacy of Acetium® capsule [...]
Akari Therapeutics announces new data demonstrating synergistic benefits of nomacopan’s bifunctional C5 and LTB4 inhibitory activity in pemphigoid disease
09/08/2019
New data from bullous pemphigoid (BP) patients and pemphigoid disease (PD) models generated by Dr. Christian Sadik’s group at University of Lubeck, Germany published in the August 2019 edition of JCI Insight (see link [...]
Cocrystal Pharma Reports Second Quarter 2019 Financial Results and Provides Corporate Update
09/08/2019
– Company continues to drive clinical and research programs forward to achieve multiple value-driving milestones– – Business development initiative underway with active discussions ongoing to secure additional strategic [...]
Tyme Technologies to Present at BTIG Biotechnology Conference on August 12th, 2019
09/08/2019
NEW YORK, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present at the [...]
Galectin Therapeutics Reports Q2 2019 Financial Results and Provides Business Update
09/08/2019
NORCROSS, Ga., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business [...]
VBI Vaccines Announces Second Quarter 2019 Financial Results and Provides Corporate Update
09/08/2019
Positive top-line data from PROTECT Phase 3 for Sci-B-Vac ® , trivalent hepatitis B vaccine, announced June 2019 – top-line data from second Phase 3 study, CONSTANT, expected around year-end 2019 ASCO presentation [...]
Acasti Pharma Co-Founder, Chief Operating and Scientific Officer to Participate on Lipid Panel at the 2019 BTIG Biotechnology Conference
09/08/2019
LAVAL, Québec, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Neoleukin Therapeutics and Aquinox Pharmaceuticals Complete Merger Transaction
09/08/2019
Nasdaq Ticker Symbol “NLTX” to be effective Monday, August 12, 2019 SEATTLE, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. (“Neoleukin”), a biopharmaceutical company utilizing sophisticated [...]
Gemphire Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
09/08/2019
LIVONIA, Mich., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company developing and commercializing therapies for the treatment of dyslipidemia, a [...]
Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession Plan
09/08/2019
Company Initiates Search for New Chief Executive Officer MORRISTOWN, N.J., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and [...]
Progenics Pharmaceuticals Announces Second Quarter 2019 Financial Results and Business Update
09/08/2019
Recorded First Revenues for AZEDRA ® ; CMS Grants New Technology Add-On Payment of Up to $98,150 per Therapeutic Dose for Inpatient Use of AZEDRA Enrollment Completed Ahead of Schedule in Phase 3 CONDOR Trial of PyL TM [...]
TG Therapeutics Provides Business Update and Reports Second Quarter 2019 Financial Results
09/08/2019
Conference call to be held today, Friday, August 9, 2019 at 8:30 AM ET NEW YORK, Aug. 09, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the second quarter ended [...]
Melinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
09/08/2019
~ Revenue of $16.0 million, Including Net Product Sales of $13.8 million, for the Second Quarter 2019 ~ ~ Reduction of Operating Expenses of 32 Percent, or $16.3 million, Year-Over-Year ~ ~ Commenced Enrollment in [...]
Organogenesis Holdings Inc. Reports Second Quarter and First Half 2019 Financial Results
09/08/2019
CANTON, Mass., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions [...]
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
09/08/2019
THE WOODLANDS, Texas, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Jeffrey L. Wade, J.D., Executive Vice President, Corporate and Administrative Affairs and Chief [...]
Voyager Therapeutics Reports Second Quarter 2019 Financial Results and Corporate Highlights
09/08/2019
Gained worldwide rights to VY-HTT01 for Huntington’s disease, expanding wholly-owned pipeline Presented additional Phase 1b results for VY-AADC in patients with Parkinson’s disease at the 2019 American Academy of [...]
Axovant Announces Corporate Updates and Financial Results for First Fiscal Quarter Ended June 30, 2019
09/08/2019
SUNRISE-PD Phase 2 trial of AXO-LENTI-PD for Parkinson's disease continues to enroll patients in second dose cohort with data expected in the fourth quarter of calendar 2019 Data from patients dosed with AXO-AAV-GM1 and [...]
ContraFect Reports Second Quarter 2019 Financial Results and Provides Business Update
09/08/2019
YONKERS, N.Y., Aug. 09, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and [...]

Pages